Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cumulative Dose, 2-Way Crossover Study of the Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler Compared With MDI in Subjects With Asthma

NCT03643874 is registered in ClinicalTrials.gov with Concentrx Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03643874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03643874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cumulative Dose, 2-Way Crossover Study of the Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler Compared With MDI in Subjects With Asthma
Lead sponsor
Concentrx Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2018
Completion date
September 30, 2018
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma